Treatment Indications: correction of fine to moderate facial wrinkles, volume restoration in delicate areas (tear troughs, perioral zone),, lip contouring, improvement of skin texture and hydration in superficial to mid dermal layers
Release form: 1 × 1.0 mL pre‑filled sterile syringe (needles 27G and 30G included)
Compound: monophasic, cross‑linked hyaluronic acid (non‑animal origin) with minimized BDDE content; features cohesive gel structure and optimized viscoelasticity
Concentration of GC: 20 mg/mL
Lidocaine: 0.3%
Indications: aesthetic correction of superficial and moderate wrinkles, mild volume deficit in facial compartments requiring soft gel consistency, refinement of delicate contours with natural integration into surrounding tissues